ClinConnect ClinConnect Logo
Search / Trial NCT06220786

Low Level Laser Therapy for Better Wound Healing

Launched by ST. ELISABETHEN KRANKENHAUS FRANKFURT GMBH · Jan 23, 2024

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of low-level laser therapy on wound healing after a cesarean section or vaginal tear. The goal is to see if using this type of laser therapy can help reduce pain and improve healing at the time of discharge and again at one and three months later. The trial is currently looking for women aged 18 and older who have had a cesarean section or a perineal tear that is classified as grade 1 to 4. Participants must be able to speak German and must provide their consent to join the study.

If you decide to participate, you will be randomly assigned to one of two groups: one group will receive the low-level laser therapy, while the other will not receive this treatment. Throughout the study, your pain levels and wound healing will be assessed, helping researchers understand if the laser therapy makes a difference. This is a great opportunity to contribute to medical knowledge that could benefit future patients!

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Caesarean section or perineal tear grade 1-4 or episiotomy
  • competent in German language
  • Exclusion Criteria:
  • no caesarean section or birth without perineal tear grad 1-4 / episiotomy
  • No consent given

About St. Elisabethen Krankenhaus Frankfurt Gmbh

St. Elisabethen Krankenhaus Frankfurt GmbH is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. Located in Frankfurt, Germany, the hospital offers a comprehensive range of services across various specialties, emphasizing patient-centered approaches and innovative treatment solutions. As a clinical trial sponsor, St. Elisabethen Krankenhaus is committed to fostering medical advancements through rigorous research protocols, ensuring compliance with ethical standards, and contributing valuable insights to the medical community. Their collaborative efforts with healthcare professionals and researchers aim to improve patient outcomes and enhance the understanding of various health conditions.

Locations

Frankfurt, Hessen, Germany

Patients applied

0 patients applied

Trial Officials

Joscha Reinhard, Prof. Dr.

Principal Investigator

St. Elisabethenkrankenhaus Frankfurt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported